Takotsubo Syndrome in COVID-19 Requires Elucidation of the Pathophysiological Background

類似資料

• Beneficiality of levosimendan for Takotsubo syndrome remains uncertain
  著者:: Finsterer, Josef, 等
  出版事項: (2019)
• SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome
  著者:: Finsterer, Josef, 等
  出版事項: (2021)
• Update on the neurology of COVID‐19
  著者:: Finsterer, Josef, 等
  出版事項: (2020)
• What triggers Takotsubo in cases without an obvious trigger?
  著者:: Finsterer, Josef, 等
  出版事項: (2019)
• Reinforce work-up for myopathy in Takotsubo syndrome
  著者:: Finsterer, Josef, 等
  出版事項: (2014)